TAYLOR COPE: Open Payments
NPI 1538818018 · JONESBORO, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$806 in 35 payments from 13 companies in 2025. Trend: 2023 $248 · 2024 $777 · 2025 $806
Food & beverage: $793Education: $14
| Company | Payments | Amount |
|---|---|---|
| Vifor Pharma, Inc. | 7 | $145 |
| Ardelyx, Inc. | 5 | $139 |
| Calliditas Therapeutics US Inc. | 4 | $128 |
| Novartis Pharmaceuticals Corporation | 4 | $105 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $84 |
| AKEBIA THERAPEUTICS INC | 2 | $51 |
| Novo Nordisk Inc | 2 | $31 |
| Mallinckrodt Hospital Products Inc. | 1 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| Aurinia Pharma U.S., Inc. | 1 | $25 |
Products named: IBSRELA, Veltassa, TARPEYO, JARDIANCE, Vafseo, Rybelsus, ACTHAR, VOYXACT.
Industry payments across AR — which companies pay providers there.
